Amphastar Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of AMPH for the last quarter is 171.84 M USD, and it's 3.52% lower compared to the previous quarter. The net income of Q1 24 is 43.18 M USD.